Icagen Quick Ratio (ICGND) starting from the third quarter 2019 to third quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Icagen, Inc.  (ICGND)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Icagen's Quick Ratio

ICGND's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Icagen's Cash & cash equivalent grew by 131.2 % in the Q3 2019 sequentially, faster than Current Liabilities, this led to improvement in Icagen's Quick Ratio to 0.12, Quick Ratio remained below Icagen, Inc. average.

Within Medical Laboratories industry 39 other companies have achieved higher Quick Ratio than Icagen in third quarter 2019. While Quick Ratio total ranking has improved so far during the Q3 2019 to 4033, from total ranking in the second quarter 2019 at 4360.

Explain Quick Ratio?
How much Cash & cash equivalents ICGND´s has?
What are ICGND´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ICGND Quick Ratio (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1		 (Dec 31 2018)
Q4		 (Sep 30 2018)
Q3
Y / Y Current Liabilities Change 158.68 % 92.66 % 113.69 % 156.09 % -13.15 %
Y / Y Cash & cash equivalent Change -27.22 % -44.19 % 146.42 % 49.05 % -50.97 %
Quick Ratio MRQ 0.12 0.08 0.24 0.38 0.43
ICGND's Total Ranking # 4033 # 4360 # 3933 # 2777 # 2647
Seq. Current Liabilities Change 48.98 % 7.22 % 2.67 % 57.71 % 10.96 %
Seq. Cash & cash equivalent Change 131.2 % -65.34 % -34.86 % 39.43 % 77.29 %



Quick Ratio third quarter 2019 Company Ranking
Within: No.
Medical Laboratories Industry # 40
Healthcare Sector # 884
Overall Market # 4033


Quick Ratio Statistics
High Average Low
5.76 1.22 0.08
(Mar 31 2015)   (Jun 30 2019)




Financial Statements
Icagen's Current Liabilities $ 18 Millions Visit ICGND's Balance sheet
Icagen's Cash & cash equivalent $ 2 Millions Visit ICGND's Balance sheet
Source of ICGND's Sales Visit ICGND's Sales by Geography


Cumulative Icagen's Quick Ratio

ICGND's Quick Ratio for the trailling 12 Months

ICGND Quick Ratio

 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months		 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 129.61 % 73.15 % 37.95 % -5.83 % -42.77 %
Y / Y Cash & cash equivalent TTM Growth 16.63 % -7.43 % -27.13 % -43.35 % -56.6 %
Quick Ratio TTM 0.19 0.26 0.32 0.33 0.37
Total Ranking TTM # 2965 # 2692 # 2545 # 2780 # 2554
Seq. Current Liabilities TTM Growth 26.75 % 16.38 % 20.34 % 29.35 % -4.42 %
Seq. Cash & cash equivalent TTM Growth -7.53 % -6.45 % 16.22 % 16 % -26.6 %

Quick ratio ranking by company, industry and sector >> Back to ICGND Financial Strength Comparisons >> Go to Compare ICGND Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q3 2019 to $17.94 millions, cumulative Quick Ratio decreased to 0.19 below the Icagen, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 35 other companies have achieved higher Quick Ratio than Icagen. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2019 from 4862 to 4864.

Explain Quick Ratio?
How much Cash & cash equivalents ICGND´s has?
What are ICGND´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 36
Healthcare Sector # 925
Within the Market # 4033


trailing twelve months Quick Ratio Statistics
High Average Low
3.15 0.91 0.2
(Sep 30 2015)   (Sep 30 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2019, within Medical Laboratories Industry Quick RatioSep 30 2019 MRQ Cash & cash equivalentSep 30 2019 MRQ Current Liabilities
Charles River Laboratories International inc   0.32 $ 164.759  Millions$ 515.551  Millions
Radnet Inc   0.29 $ 68.560  Millions$ 236.113  Millions
WEED, INC.  0.27 $ 0.104  Millions$ 0.387  Millions
Quest Diagnostics Inc  0.23 $ 434.000  Millions$ 1,864.000  Millions
Koninklijke Philips Nv  0.23 $ 1,794.240  Millions$ 7,815.360  Millions
Nrc Health  0.22 $ 8.358  Millions$ 38.312  Millions
Pra Health Sciences Inc   0.21 $ 181.790  Millions$ 872.703  Millions
Vyant Bio Inc   0.19 $ 2.447  Millions$ 12.675  Millions
American Shared Hospital Services  0.19 $ 1.647  Millions$ 8.778  Millions
Kushco Holdings Inc   0.17 $ 3.944  Millions$ 23.168  Millions
Labcorp Holdings Inc   0.15 $ 361.100  Millions$ 2,344.500  Millions
Grapefruit Usa Inc   0.12 $ 0.467  Millions$ 3.763  Millions
Icagen, Inc.  0.12 $ 2.150  Millions$ 17.941  Millions
Capforce Inc   0.10 $ 0.626  Millions$ 6.434  Millions
Inotiv Inc   0.03 $ 0.606  Millions$ 17.481  Millions

Date modified: 2026-09-08T15:09:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.